Healthcare
Menicon Co Ltd(MECNY)
Live Price
Offline$88.63
+0.00% today
Window Change
+0.00%
Window
Jun 23, 2025 โ Apr 6, 2026
- Market Cap
- $26.87B
- Revenue Growth
- +4.6%
- EPS Growth
- +24.1%
- Dividend Yield
- 0.0%
Historical coverage is still expanding
This 1Y daily history view is usable, but not fully loaded yet. Additional bars will appear as backfills continue.
Coverage: 198 bars ยท Jun 23, 2025 โ Apr 6, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Menicon Co Ltd (MECNY) is a Healthcare stock with a market cap of $26.87B and listed on OTC. The stock last traded around $88.63 and up 0.0% across the available one-year price window (Jun 23, 2025 โ Apr 6, 2026). Baseline metrics include revenue growth of +4.6%, EPS growth of +24.1%, a dividend yield of 0.0%. What stands out right now is revenue +4.6%, EPS +24.1%, free cash flow +62.6% with operating margin 20.3% and ROIC 4.3%. Valuation already assumes a fairly strong business story at P/E 11275.3 and price/sales 71.4. Stock Foundry combines MECNY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
+4.6% vs +7.6% peer median
Operating Margin
Near sector median
+20.3% vs +19.4% peer median
P/E
Above sector median
11275.3 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2025 was reported on Aug 12, 2025, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +4.6% and EPS at +24.1%, with operating margin around 20.3%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged 0.0% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2025 Aug 12, 2025 | โ | +0.0% | +0.0% | +0.0% |
2025 May 14, 2025 | โ | +0.0% | +0.0% | +0.0% |
2025 Feb 11, 2025 | โ | +0.0% | +0.0% | +0.0% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
MECNY
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
MECNY Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for MECNY and SPY.
Company Overview
Menicon Co Ltd
Other OTC
Menicon Co Ltd is a contact lens manufacturing company. It is involved in manufacturing, sales, export, and import of contact lenses and other medical goods, manufacturing and sales of medical instruments, sales of medical supplies and research and development of intraocular lenses. The firm's products include soft lenses, gas permeable lenses and lens care products.
- Leadership
- Koji Kawaura
- IPO Date
- Oct 1, 2021
- Employees
- 4.3k
- Street Address
- 3-21-19, Aoi, Naka-ku
- Mailing
- Nagoya, 460-0006
- Region
- Nagoya, US
- Reporting Currency
- USD
- Investor Line
- +81 52 935 1515
- Last Updated
- May 2, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 11275.3
- EV/EBITDA
- 517.5
- Price/Sales
- 71.4
- Price/Book
- 195.8
Growth
- Revenue
- +4.6%
- EPS
- +24.1%
- Free Cash Flow
- +62.6%
Profitability
- Gross Margin
- 52.7%
- Operating Margin
- 20.3%
- Net Margin
- 2.5%
- ROE
- 2.3%
- ROIC
- 4.3%
Balance Sheet
- Debt/Equity
- 0.89
- Current Ratio
- 2.82
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.